Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
Health
Jane Kirby

‘Game-changing’ breast cancer pill to be offered on NHS

A "huge breakthrough" in breast cancer treatment has arrived with the NHS approval of a twice-daily pill for the most common form of advanced disease.

The drug, capivasertib (also known as Truqap), offers new hope for up to 3,000 women annually with hormone receptor (HR)-positive, HER2-negative breast cancer harbouring specific genetic mutations and exhibiting spread.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.